These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7588202

  • 1. Metabolism of 1 alpha-hydroxyvitamin D2 to activated dihydroxyvitamin D 2 metabolites decreases endogenous 1 alpha, 25-dihydroxyvitamin D 3 in rats and monkeys.
    Knutson JC, Hollis BW, LeVan LW, Valliere C, Gould KG, Bishop CW.
    Endocrinology; 1995 Nov; 136(11):4749-53. PubMed ID: 7588202
    [Abstract] [Full Text] [Related]

  • 2. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR, Baylink DJ, Jones PG, Haussler MR.
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and systemic effect on calcium homeostasis of 1 alpha,24-dihydroxyvitamin D2 in rats. Comparison with 1 alpha,25-dihydroxyvitamin D2, calcitriol, and calcipotriol.
    Knutson JC, LeVan LW, Valliere CR, Bishop CW.
    Biochem Pharmacol; 1997 Mar 21; 53(6):829-37. PubMed ID: 9113104
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 21; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. 1alpha-hydroxyvitamin D2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats.
    Erben RG, Bante U, Birner H, Stangassinger M.
    Calcif Tissue Int; 1997 May 21; 60(5):449-56. PubMed ID: 9115163
    [Abstract] [Full Text] [Related]

  • 7. Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation.
    Biancuzzo RM, Clarke N, Reitz RE, Travison TG, Holick MF.
    J Clin Endocrinol Metab; 2013 Mar 21; 98(3):973-9. PubMed ID: 23386645
    [Abstract] [Full Text] [Related]

  • 8. In vitro metabolism of 19-nor-1alpha, 25-(OH)2D2 in cultured cell lines: inducible synthesis of lipid- and water-soluble metabolites.
    Shankar VN, Propp AE, Schroeder N, Surber BW, Makin HL, Jones G.
    Arch Biochem Biophys; 2001 Mar 15; 387(2):297-306. PubMed ID: 11370854
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biological activity of 1,25-dihydroxyvitamin D2 and 24-epi-1,25-dihydroxyvitamin D2.
    DeLuca HF, Sicinski RR, Tanaka Y, Stern PH, Smith CM.
    Am J Physiol; 1988 Apr 15; 254(4 Pt 1):E402-6. PubMed ID: 2833108
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
    Finch JL, Brown AJ, Slatopolsky E.
    J Am Soc Nephrol; 1999 May 15; 10(5):980-5. PubMed ID: 10232683
    [Abstract] [Full Text] [Related]

  • 13. 1 alpha,24(S)-dihydroxyvitamin D2: a biologically active product of 1 alpha-hydroxyvitamin D2 made in the human hepatoma, Hep3B.
    Strugnell S, Byford V, Makin HL, Moriarty RM, Gilardi R, LeVan LW, Knutson JC, Bishop CW, Jones G.
    Biochem J; 1995 Aug 15; 310 ( Pt 1)(Pt 1):233-41. PubMed ID: 7646451
    [Abstract] [Full Text] [Related]

  • 14. Displacement potency of vitamin D2 analogs in competitive protein-binding assays for 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D3, and 1,25-dihydroxyvitamin D3.
    Jones G, Byrnes B, Palma F, Segev D, Mazur Y.
    J Clin Endocrinol Metab; 1980 Apr 15; 50(4):773-5. PubMed ID: 6965943
    [Abstract] [Full Text] [Related]

  • 15. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y, Knutson JC, Bishop C, Shany S.
    Anticancer Res; 1998 Apr 15; 18(3A):1769-75. PubMed ID: 9673403
    [Abstract] [Full Text] [Related]

  • 16. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 15; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 17. Discrepancy between serum concentrations of 1,25-dihydroxyvitamin D metabolites measured by radio-immunoassay and thymus radioreceptor assay during vitamin D2 treatment.
    Hartwell D, Johansen JS, Christiansen C.
    Scand J Clin Lab Invest; 1989 Oct 15; 49(6):545-53. PubMed ID: 2556781
    [Abstract] [Full Text] [Related]

  • 18. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies.
    Reinhardt TA, Horst RL, Orf JW, Hollis BW.
    J Clin Endocrinol Metab; 1984 Jan 15; 58(1):91-8. PubMed ID: 6605973
    [Abstract] [Full Text] [Related]

  • 19. Evidence for the activation of 1alpha-hydroxyvitamin D2 by 25-hydroxyvitamin D-24-hydroxylase: delineation of pathways involving 1alpha,24-dihydroxyvitamin D2 and 1alpha,25-dihydroxyvitamin D2.
    Masuda S, Strugnell SA, Knutson JC, St-Arnaud R, Jones G.
    Biochim Biophys Acta; 2006 Feb 15; 1761(2):221-34. PubMed ID: 16516540
    [Abstract] [Full Text] [Related]

  • 20. Determination of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in human serum using liquid chromatography with tandem mass spectrometry.
    Fang H, Yu S, Cheng Q, Cheng X, Han J, Qin X, Xia L, Jiang X, Qiu L.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug 01; 1027():19-26. PubMed ID: 27240300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.